HomeGeneralFujitsu and University of Tokyo Hospital Embark on Joint Research into AI...

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

- Advertisement -spot_img

TOKYO, Oct 11, 2021 – (JCN Newswire) – Fujitsu Limited today revealed that it has actually begun joint scientific research study with the University of Tokyo Hospital to confirm the efficiency of expert system innovation to approximate irregular heart motions based upon electrocardiogram( 1) information. The research study is prepared to start at the University of Tokyo Hospital from October 25.

Flow of the Clinical Research

Since December 2019, Fujitsu has actually been making development with research study and advancement of exclusive AI innovation( 2) in cooperation with the University of Tokyo Hospital. This research study makes use of information from clients that have actually checked out the University of Tokyo Hospital to date and consists of around 630,000 pieces of electrocardiographic information and information from roughly 140,000 heart ultrasounds (echocardiography)( 3 ). This effort has actually now prospered in finding clients with irregular heart motions with high precision.

The AI will be utilized in scientific field research study to approximate the existence or lack of irregular heart motions based upon the information of clients going through electrocardiographic treatments at the University of Tokyo Hospital. Clients recognized by the AI as having irregular heart motions will go through echocardiography, and the efficiency will be confirmed by comparing the outcomes of medical professionals’ medical diagnosis with the outcomes forecasted by the AI. Fujitsu will take advantage of this AI to spot cardiovascular disease at an early phase to avoid development to severe disease in clients and enhance its vision of “Healthy Living”, promoting wellness for individuals throughout society.

This effort will be presented at Fujitsu ActivateNow 2021, a worldwide occasion to be held from October 12 in online format.


Heart illness is the 2nd leading cause of death in Japan (4 ), and electrocardiography, which finds problems in the heart muscle and irregular pulses based upon the waveform of electrical pulses in the heart, is extensively utilized as a diagnostic tool to identify heart problem at an early phase. It stays hard, nevertheless, to discover problems in the shape and motion of the heart utilizing just electrocardiograms. In medical practice, in addition to electrocardiography, medical professionals utilize a stethoscope to find unusual heart noises (whisperings, arrythmia, and so on) based upon the client’s description of their signs, followed by echocardiography to find irregularities in heart shape and motion. Due to the fact that echocardiographic diagnostics can just be carried out in a minimal number of centers with specialized physicians and lab service technicians, it is tough to use this for all clients. This makes early detection hard, and when issues are discovered, the development of the illness might currently be advanced. In the treatment of heart problem, early detection and suitable treatment are an essential concern in medical practice.

Since December 2019, in cooperation with a research study group headed by Dr. Katsuhito Fujiu, Project Associate Professor, and Dr. Issei Komuro, Professor in the Department of Cardiovascular Medicine at the University of Tokyo Hospital, Fujitsu has actually been participated in research study and advancement making use of AI to identify heart problem from electrocardiogram information, leveraging Fujitsu’s exclusive waveform analysis innovation, TDA (topological information analysis) (5 ). Moving forward, Fujitsu will work to validate the efficiency of AI in real medical practice to approximate the existence or lack of problems in heart function from electrocardiogram information, and will begin medical research study at the University of Tokyo Hospital.

Clinical Research Overview

Based on the electrocardiogram information of clients analyzed at the University of Tokyo Hospital, Fujitsu and the University of Tokyo Hospital will validate the efficiency of detection of unusual heart motion by AI.

1. Period

From October 25, 2021 (Monday) to March 31, 2022 (Thursday) (Planned)

2. Area

Department of Cardiovascular Medicine, the University of Tokyo Hospital

3. Scientific Research Activity: screening expert system to approximate irregular heart motions

Fujitsu will set up a server geared up with AI to discover irregularities in heart motion at the University of Tokyo Hospital and link it to a server that shops electrocardiogram information, examine the client’s electrocardiogram, and approximate the existence or lack of unusual heart motions. Echocardiography is carried out on clients the AI forecasts to have unusual heart motions, and physicians identify whether heart problem exists.

4. Department of functions

Fujitsu: Install and run AI-powered servers

The University of Tokyo Hospital: Input of the client’s electrocardiogram information into the AI, echocardiography if the AI thinks an irregularity, and checking the efficiency of the AI based upon the outcomes.

Future Plans

Based on the outcomes of this medical research study, Fujitsu will promote research study and advancement of options that can discover irregularities in heart movement at an early phase and add to the avoidance of development to major cardiovascular disease in clients. Through its joint research study with the University of Tokyo Hospital, Fujitsu will continue to actively promote research study and advancement of AI to find different cardiovascular disease. Eventually, by working to take advantage of the outcomes of these efforts to add to the resolution of medical issues challenging society, Fujitsu will assist provide higher trust and wellness to society, and drive the advancement of innovations and services that promote its vision of “Healthy Living”.

( 1) Electrocardiogram:

A record of modifications in the electrical capacity of the heart.

( 2) Research and advancement on their special AI:

Conducted in accordance with the University of Tokyo Hospital Code of Ethics.

( 3) Echocardiography:

An ultrasound scan of the chest that evaluates and images the shown waves to examine the heart’s mechanical functions, consisting of motion and shape.

( 4) The 2nd leading cause of death in Japan:

From the report of “Summary of Vital Statistics” (the Ministry of Health, Labour and Welfare).

( 5) TDA (Topological Data Analysis):

An information analysis technique that deals with information as a set of points set up in an area and extracts geometric details of the set.

Fujitsu’s Commitment to the Sustainable Development Goals (SDGs)

The Sustainable Development Goals (SDGs) embraced by the United Nations in 2015 represent a set of typical objectives to be attained around the world by2030 Fujitsu’s function– “to make the world more sustainable by developing rely on society through development”– is a pledge to add to the vision of a much better future empowered by the SDGs.

About Fujitsu

Fujitsu is the leading Japanese info and interaction innovation (ICT) business using a complete series of innovation items, options and services. Around 126,000 Fujitsu individuals support consumers in more than 100 nations. We utilize our experience and the power of ICT to form the future of society with our consumers. Fujitsu Limited (TSE: 6702) reported combined profits of 3.6 trillion yen (US$34 billion) for the ended March 31,2021 For more details, please see www.fujitsu.com.

Topic: Press release summary

Source: Fujitsu Ltd

Sectors: Artificial Intel [AI], MedTech


From the Asia Corporate News Network

Copyright © 2021 ACN Newswire. All rights scheduled. A department of Asia Corporate News Network.

- Advertisement -spot_img
- Advertisement -spot_img
Stay Connected
Must Read
- Advertisement -spot_img
Related News
- Advertisement -spot_img


Please enter your comment!
Please enter your name here